HEALTHPEAK PROPERTIES, INC. 10-K — AI Bull & Bear Analysis

The 2025 10-K reveals a company in the midst of a high-stakes transition. Healthpeak is successfully upgrading its asset quality and diversifying into life sciences, but these operational wins are currently offset by a fragile balance sheet. The tension between the company's strategic pivot and its immediate liquidity needs suggests a narrow margin for error as it approaches its 2026 debt maturities. Ultimately, the investment case hinges on the successful execution of the Janus Living IPO and the ability to refinance debt without excessive dilution. While the shift toward outpatient and lab assets provides a long-term growth path, the immediate risk remains a potential liquidity crunch that could force a re-evaluation of development goals or dividend sustainability.